Recruiting PHASE1 INTERVENTIONAL 4-arm
NCT07251608
Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus
Randomized, Open-Label, Safety Pilot Study of Multiple Subcutaneous and Intramuscular Injections of Niagen® Plus
Sponsor: ChromaDex, Inc.
Conditions
Fatigue Healthy Volunteer
Interventions
Niagen®Plus
Updated 1 time since 2025 Last updated: Nov 19, 2025 Started: Oct 1, 2025 Primary completion: Feb 15, 2026 Completion: Feb 15, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07251608, this PHASE1 trial focuses on Fatigue and Healthy Volunteer and remains actively recruiting participants. Sponsored by ChromaDex, Inc., it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- ChromaDex, Inc.
Data source: ChromaDex, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .